LONDON -- In my previous pick-of-the-sector report, I went for GlaxoSmithKline in the pharmaceuticals sector, and today I'm turning my attention to the banking industry. There are some who wouldn't trust a penny of their investment money to a bank, but there must be a price at which they're worth buying, mustn't there?
I'm making my pick from the five banks listed on the FTSE 100, which are Barclays (LSE:BARC), Royal Bank of Scotland Group (LSE:RBS), Lloyds Banking Group (LSE:LLOY) HSBC Holdings (LSE:HSBA), and Standard Chartered (LSE:STAN)
Here are some numbers:
|Share price growth||+46%||+130%||+78%||+50%||+21%|
|Historic EPS growth||-20%||n/a||+24%||n/a||+14%|
|Forward EPS growth||+33%||n/a||+3%||+265%||+3%|
Share price growth is over the past 12 months, historic figures are for December 2012, forward figures are based on December 2013 forecasts.
I do quite like the look of Standard Chartered. It's on a modest price-to-earnings (P/E) ratio, both historic and prospective, and pays a decent dividend. And perhaps more importantly, it does most of its business in Asia and escaped the worst of the Western banking crisis -- and wasn't involved in mis-selling or LIBOR-fixing scandals, or anything like that. But it's for those reasons that Standard Chartered is not my choice -- it's hard to compare with the others, and I really want to look at U.K. high-street banks.
There's really no disputing that the two bailed-out banks, Lloyds and RBS, are on the road to recovery -- and they've already rewarded investors over the past couple of years, although RBS shares have slumped since the start of this year. But since the bailout, taxpayers are actually still sitting on losses with both banks.
One thing that makes these both unattractive to me, though, is how hard it is to value them at this stage in their turnaround. Both are trading at less than net asset value, with RBS on a price-to-book value of only 0.3, which suggests there's value there -- but we have P/E values that can't really mean much at the turnaround point, and no dividends to speak of. We also have no idea what the government will do with our taxpayers' stake, or when anything will happen, and I tend to steer away from companies whose valuations are so much at the whim of governments. So these two are also out for me.
Last two standing
For me it's down to Barclays or HSBC, and I do like the latter. But HSBC looks reasonably fully valued to me -- the shares are selling for around 1.3 times net asset value and P/E is a little below the FTSE's long-term average, though there's a decent dividend expected of 4.6%.
Barclays, on the other hand, currently looks undervalued on its forward P/E of just under 9 and with a PBV of only 0.7. There's a dividend yield of a modest 2.3% expected this year. But it should be nearly five times covered, suggesting there's plenty of scope for future increases -- even if the bank has had to set aside more than 3 billion pounds to cover the mis-selling of payment protection insurance and interest rate hedging products.
Is Barclays cheap?
Of course, some will say that's a good reason for Barclays to be lowly valued. And it was, after all, also fined a total of 290 million pounds for its part in attempting to manipulate the interbank LIBOR rate. But I reckon a good time to buy a share is when sentiment is against it, and sentiment does seem to be against Barclays despite some important changes.
Bob Diamond, head of the bank at the time of its shadiest days, has gone, as have two of the bank's divisional bosses who were close to him, investment banking head Rich Ricci and wealth management head Tom Kalaris. New chief exectutive Antony Jenkins seems like the much-needed new broom.
For those reasons, Barclays is my pick of the FTSE 100 banking sector.
Finally, if you're looking for investments that should take you all the way to a comfortable retirement, I recommend the Fool's special new report detailing five blue-chip shares. They'll be familiar names to many, and they've already provided investors with decades of profits.
But the report will only be available for a limited period, so click here to get your hands on these great ideas -- they could set you on the road to long-term riches.
Alan does not own any shares mentioned in this article. The Motley Fool owns shares in Standard Chartered. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.